Approval · Notice of Compliance 22997 · 2019
XEMBIFY: Notice of Compliance 22997
Issued December 10, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22997
- Date
- December 10, 2019
- Company
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| XEMBIFY | 02494426 | Approved |
Medicinal ingredients
- IMMUNOGLOBULIN (HUMAN) 20 PER per VIAL